-
Yosibi Siminja ® (Pesseli Pearl mono-anti-injection) approved by the State Drug Administration
Time of Update: 2020-06-09
recently, it has been reported that the global bio pharmaceutical (http:// company (http:// Yushibi announced that its Ximinja ® (Pesseli pearl mono-injection) has been approved by the National
-
FDA accepts new drug application from Jansen Invokana (canagliflozin, Cagrenet)
Time of Update: 2020-06-09
diabetes is the leading cause of renal failure, affecting millions of patients around the world, but there are few effective long-term treatments recently, janssen Pharmaceutical s company janssen
-
AstraZeneca chronic nephrotic anemia drug Roxadustat (Rosastat) has achieved positive results in two Phase III clinical trials
Time of Update: 2020-06-09
recently, AstraZeneca announced that its chronic kidney disease anemia drug (http:// Roxadustat in China conducted two Phase III clinical results, trial (http:// results have proved that the d
-
FDA grants Fosun Pharma ORIN1001 fast-track eligibility for breast cancer treatment
Time of Update: 2020-06-09
recently, Fosun Medicines (http:// (stock code: 600196 SH, 02196.HK) and the announcement that the U.S Food and Drug (http:// Regulatory Authority ( FDA (http:// ) has recently granted it a
-
Mercadon dog antiparasitic oral drug freellana chewing tablets are available in China
Time of Update: 2020-06-09
recently, Mercadong Animal Health announced that its canine antiparasitic oral drug (http:// frererana chewing tablets are available in China to treat flea and tick infections in canine body watc
-
Novartis multiple sclerosis drug Fengomode gets FDA approval to go on the market
Time of Update: 2020-06-09
recently, Novart is multi- drug (http:// Fengomode was approved for marketing by the National Drug (http:// Regulatory Authority, the second new drug (http:// ) approved in China for oral mul
-
FDA approves Samsung Bioepis company Hadlima for treatment of a variety of autoimmune diseases
Time of Update: 2020-06-09
, south Korea's bio pharmaceutical (http:// company (http:// Samsung Bioepis announced that the U.S Food and Drug (http:// Authority ( FDA (http:// ) has approved Hadlima (adalimumab-bwwd,
-
Yisheng Bio's new rabies vaccine production workshop through GMP certification
Time of Update: 2020-06-09
today, the company (http:// of the Limited of the Pharmaceutical (http:// announced that the company's Liaoning Yisheng Biopharmaceutical Co., Ltd has obtained the GMP certification for the ne
-
FDA grants EngleNet (SGLT-2 inhibitor) fast-track qualification
Time of Update: 2020-06-09
recently, Bollinger Ingeheim/Lilly announced The FDA (http:// granted TheNGLNet (SGLT-2 inhibitor) fast-track eligibility to reduce the risk of cardiovascular death and hospitalization for heart
-
Sansheng Pharmaceutical Antibody Drug Product sinia® (recombinant anti-CD25 human-derived monoclonal antibody injection) obtains drug GMP certificate
Time of Update: 2020-06-09
yesterday (June 25), China's leading bio pharmaceutical (http:// company (http:// Sansheng Pharmaceuticals (01530 HK) announced that the company's self-developed antibody drug (http:// produ
-
Reed Pharma Announces Nirapali (Zhele) Approved for Listing in Macau, China
Time of Update: 2020-06-09
recently, the Pharmaceutical (http:// announced that Nirapali (ZL2306) has been approved for the market in Macau, China, for the treatment of platinum-sensitive, recurrent high-level plasma ophth
-
Pfizer's oral PARP inhibitor TALZENNA ® has been approved by the European Commission
Time of Update: 2020-06-09
recently, Pfizer announced that its oral PARP inhibitor TALZENNA ® (talazoparib) has been approved by the European Commission as a single drug to treat breast cancer susceptibility gene (gBRCA) 1/2
-
New drug brief application for injection line mycobacteria D in Haizheng Pharmaceuticals obtains FDA review approval
Time of Update: 2020-06-09
Today, Haizheng Pharmaceuticals announced that the new drug (http:// application (andA, or http:// for injection line iurethane D declared by the holding sub- company (http:// Haizheng Pharm
-
Zhengda Tianqing antifungal drug injection with acetic acid carpofen net has been approved by the State Drug Administration
Time of Update: 2020-06-09
recently, Zhengda Tianqing Pharmaceutical Group limited shares company (http:// developed antifungal drug injection with acetate carpoffin net (including 50mg and 70mg specifications) has been is
-
ViiV Healthcare has filed a new drug application for cabotegravir-based two-drug HIV combination therapy
Time of Update: 2020-06-09
today, ViiV Healthcare (http:// jointly announced that it has submitted a new drug (http:// of the of the drug HIV combination therapy of Janssen's rilpivirine and ViiV's cabotegravir, the h
-
Drug Mingconde anti-cancer drug Tibsovo (ivosidenib) a global clinical Phase 3 trial reaches the main end
Time of Update: 2020-06-09
bile duct cancer is a rare malignant tumor, according to the occurrence of the site can be divided into hepatic biliary tube cancer and hepatic exobilal bile duct cancer Existing local treatment opt
-
Ukip unveils new data on anti-inflammatory drug Cimzia (certolizumab pegol)
Time of Update: 2020-06-09
recently, Belgian Pharmaceutical (http:// giant UCB released new data on the anti-inflammatory drug Cimzia (certolizumab pegol), supporting the long-term safety of Cimzia's treatment of adult pat
-
Novo nornord Victoza extended indications obtain FDA approval
Time of Update: 2020-06-09
today, the United States the FDA announced (http:// that it has approved the expansion of Victoza (liraglutide) in the company (http:// to extend the indications of diabetes for people with ty
-
GlaxoSmithKline gets approval from China's National Drug Administration for listing
Time of Update: 2020-06-09
yesterday (July 16), GlaxoSmithKline (GSK) announced that Belista (belimumab, injection Bellevue) had been approved by the Regulatory Authority of China's Medicines (http:// for listing This tim
-
NICE recommends Novartis Kisqali and AstraZeneca Faslodex to treat breast cancer patients
Time of Update: 2020-06-09
recently, the National Health (http:// Institute for and Care Excellence (NICE) announced its recommendation to support Novartis Kisqali's association with AstraZeneca Faslodex for patients with
